Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2500 to 2549 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein 1 (hip-i). [source:swissprot;acc:o00291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10733.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9902.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0839\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1251\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrobrevin binding protein 1; dysbindin. [source:refseq;acc:nm\_032122]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5678.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6161.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
483.63\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08385\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1252\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7033.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7516.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
483.05\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08385\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1253\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribokinase (ec 2.7.1.15). [source:swissprot;acc:q9h477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6210.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6693.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
482.98\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08385\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1254\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5972.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
482.91\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
goodpasture antigen-binding protein (ec 2.7.1.37) (gpbp) (collagen type iv alpha 3 binding protein) (star-related lipid transfer protein 11) (stard11) (start domain-containing protein 11). [source:swissprot;acc:q9y5p4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10725.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9896.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0838\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1255\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 6 (ec 2.7.1.-) (map kinase kinase 6) (mapkk 6) (mapk/erk kinase 6) (sapkk3). [source:swissprot;acc:p52564]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6105.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6587.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
482.65\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 4 (ec 3.1.3.16) (pp4) (protein phosphatase x) (pp-x). [source:swissprot;acc:p33172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5893.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1256\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 3 (ec 2.7.1.-) (map kinase kinase 3) (mapkk 3) (mapk/erk kinase 3). [source:swissprot;acc:p46734]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6586.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
482.37\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein 1 related (hip1-related) (hip 12). [source:swissprot;acc:o75146]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10719\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9891.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1257\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4254.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4736.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
481.41\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5893.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0837\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1258\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate carboxypeptidase-like protein 2 precursor. [source:swissprot;acc:q96kn2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6251.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6774.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08363\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
481.1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1259\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5685.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6157.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08308\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
481.1\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1260\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5754.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6232.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08306\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1261\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
43 kda receptor-associated protein of the synapse (rapsyn) (acetylcholine receptor-associated 43 kda protein) (43 kda postsynaptic protein). [source:swissprot;acc:q13702]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6160.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6640.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
480.72\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5685.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6157.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08305\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1262\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 3 (von hippel-lindau binding protein 1) (vhl binding protein-1) (vbp-1) (hibbj46). [source:swissprot;acc:q15765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5207.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5687.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.81\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 23 (ec 2.7.1.37) (muscle-specific serine kinase 1) (mssk-1). [source:swissprot;acc:q9upe1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1263\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp binding protein 2. [source:refseq;acc:nm\_019096]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 2 (hspc231). [source:swissprot;acc:q9uhv9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5207.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5687.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.81\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1264\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uxt protein (ubiquitously expressed transcript protein) (hspc024). [source:swissprot;acc:q9ubk9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5207.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5687.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.81\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1265\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4250.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4729.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.13\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1266\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic checkpoint protein bub3. [source:swissprot;acc:o43684]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5470.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5949.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.05\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1267\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 207. [source:swissprot;acc:o43670]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5470.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5949.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
479.05\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1268\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4250.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4729.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
478.94\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1269\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal 3,2-trans-enoyl-coa isomerase (ec 5.3.3.8) (dodecenoyl-coa delta-isomerase) (d3,d2-enoyl-coa isomerase) (dbi-related protein 1) (drs-1) (hepatocellular carcinoma-associated antigen 88). [source:swissprot;acc:o75521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7048.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7527.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
478.63\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.083\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1270\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5654.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6132.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
478.23\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5685.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6156.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08292\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1271\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5654.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6132.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
478.15\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1272\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5754.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6232.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
477.99\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1273\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08261\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 7 (ec 3.4.25.1) (proteasome subunit rc6-1) (proteasome subunit xapc7). [source:swissprot;acc:o14818]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6216.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6693.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
477.26\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1274\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08261\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5980.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6457.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
477.1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08261\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/